Aridis Pharma enters option agreement with Serum Institute of India - The Pharma Letter
Aridis Pharma enters option agreement with Serum Institute of India The Pharma Letter
US biopharma firm Aridis Pharmaceuticals (Nasdaq: ARDA) announced today that it has entered into an option agreement with the Serum International BV ...
Comments
Post a Comment